A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response-Reference-Cited by-同舟云学术

A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response

Published:2012-07-29 Issue:7411 Volume:488 Page:404-408
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Kruidenier Laurens,Chung Chun-wa,Cheng Zhongjun,Liddle John,Che KaHing,Joberty Gerard,Bantscheff Marcus,Bountra Chas,Bridges Angela,Diallo Hawa,Eberhard Dirk,Hutchinson Sue,Jones Emma,Katso Roy,Leveridge Melanie,Mander Palwinder K.,Mosley Julie,Ramirez-Molina Cesar,Rowland Paul,Schofield Christopher J.,Sheppard Robert J.,Smith Julia E.,Swales Catherine,Tanner Robert,Thomas Pamela,Tumber Anthony,Drewes Gerard,Oppermann Udo,Patel Dinshaw J.,Lee Kevin,Wilson David M.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature11262.pdf

Reference25 articles.

1. Mosammaparast, N. & Shi, Y. Reversal of histone methylation: biochemical and molecular mechanisms of histone demethylases. Annu. Rev. Biochem. 79, 155–179 (2010)

2. Klose, R. J. & Zhang, Y. Regulation of histone methylation by demethylimination and demethylation. Nature Rev. Mol. Cell Biol. 8, 307–318 (2007)

3. Shi, Y. Histone lysine demethylases: emerging roles in development, physiology and disease. Nature Rev. Genet. 8, 829–833 (2007)

4. Trojer, P. & Reinberg, D. Histone lysine demethylases and their impact on epigenetics. Cell 125, 213–217 (2006)

5. Loenarz, C. & Schofield, C. J. Physiological and biochemical aspects of hydroxylations and demethylations catalyzed by human 2-oxoglutarate oxygenases. Trends Biochem. Sci. 36, 7–18 (2011)

Cited by 795 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review and new insights into the catalytic structural domains of the Fe(ll) and 2-Oxoglutarate families;International Journal of Biological Macromolecules;2024-10

2. Emerging role of Jumonji domain-containing protein D3 in inflammatory diseases;Journal of Pharmaceutical Analysis;2024-09

3. Hyperactivating EZH2 to augment H3K27me3 levels in regulatory T cells enhances immune suppression by driving early effector differentiation;Cell Reports;2024-09

4. Histone modifications and their roles in macrophage-mediated inflammation: a new target for diabetic wound healing;Frontiers in Immunology;2024-08-20

5. Branched-chain amino acid transaminase 1 confers EGFR-TKI resistance through epigenetic glycolytic activation;Signal Transduction and Targeted Therapy;2024-08-15